Apr. 14 at 4:54 PM
$GRTX Quick DD- Giant
$350M merger on a
$5M market cap. Huge play in the making here..
•
$350M in commitments oversubscribed private placement
•OBX-115 currently in Phase 2 clinical trials
•FDA Fast Track designation
•Targeting NASDAQ listing upon merger completion
“In support of the transaction, Galera and Obsidian have secured commitments for an oversubscribed private placement financing that is expected to result in total gross proceeds of
$350 million from a syndicate of new investors, including Balyasny Asset Management, Caligan Partners LP, Eventide Asset Management, Nantahala Capital, Octagon Capital, Redmile, Spruce Street Capital and Trails Edge Capital Partners, and with participation from current Obsidian investors, including Atlas Venture, Deep Track Capital, Foresite Capital, Janus Henderson Investors, Logos Capital, Novo Holdings A/S, Paradigm BioCapital Advisors, Pivotal bioVenture Partners, RA Capital Management, RTW Investments, TCGX….